Univariate and multivariate analyses to determine the factors for patients with 
hepatitis B, tumor, hepatocellular carcinoma, portal vein tumor thrombosis
HEPATITIS B, VIRUS, HEPATOCELLULAR CARCINOMA, TUMOR
Afterward, we explored the risk factors associated with EHR. First, all 227 patients were randomly divided into development (A comparison of the characteristics of patients between the derivation set and validation set.
Abbreviations: AFP, alpha‐fetoprotein; HBsAg, hepatitis B surface antigen; HBV‐DNA, hepatitis B virus DNA; MVD, microvessel density; MVI, microvascular invasion; PVTT, portal vein tumor thrombosis.In the development cohort, univariate analysis revealed that total CTC counts, AFP, tumor size, Edmondson grade, node number, tumor capsule, KI67, and MVI/PVTT status were significantly associated with EHR after hepatectomy (all Clinicopathological factors associated with EHR of hepatocellular carcinoma in the training cohort.Abbreviations: AFP, alpha‐fetoprotein; HBsAg, hepatitis B surface antigen; HBV‐DNA, hepatitis B virus DNA; MVD, microvessel density; MVI, microvascular invasion; PVTT, portal vein tumor thrombosis.